 | • レポートコード：D005-15397 • 出版社/出版日：GlobalInfoResearch / 2020年5月26日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、テルミサルタンの世界市場を広く調査・分析し、今後の市場展望をまとめております。テルミサルタンの種類別市場規模（注射、フリーズドライパウダー）、用途別市場規模（病院用、クリニック用、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Bayer、Novartis、Teva、Hema Pharmaceuticals Pvt、Boehringer Ingelheim、Astellas Pharma Inc、Reddy's Laboratories (UK)、Mylan、GSK、Nippon Boehringer Ingelheim、Beijing Wansheng Pharmaceutical、Abbott、Takeda ・地域別グローバル市場分析 2015年-2020年 ・テルミサルタンの北米市場（アメリカ、カナダ、メキシコ） ・テルミサルタンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・テルミサルタンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・テルミサルタンの南米市場（ブラジル、アルゼンチン） ・テルミサルタンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：注射、フリーズドライパウダー ・用途別分析：病院用、クリニック用、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Telmisartan market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 0.8% in the forecast period of 2020 to 2025 and will expected to reach USD 3521.8 million by 2025, from USD 3416.8 million in 2019.
The Telmisartan market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Telmisartan market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Telmisartan market has been segmented into
Injection
Freeze-Dried Powder
By Application, Telmisartan has been segmented into:
Hospital Use
Clinic Use
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Telmisartan market presented in the report. This section sheds light on the sales growth of different regional and country-level Telmisartan markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Telmisartan market.
The report offers in-depth assessment of the growth and other aspects of the Telmisartan market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Telmisartan Market Share Analysis
Telmisartan competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Telmisartan sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Telmisartan sales, revenue and market share for each player covered in this report.
The major players covered in Telmisartan are:
Pfizer
Bayer
Novartis
Teva
Hema Pharmaceuticals Pvt
Boehringer Ingelheim
Astellas Pharma Inc
Reddy’s Laboratories (UK)
Mylan
GSK
Nippon Boehringer Ingelheim
Beijing Wansheng Pharmaceutical
Abbott
Takeda
Among other players domestic and global, Telmisartan market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Telmisartan product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Telmisartan, with price, sales, revenue and global market share of Telmisartan in 2018 and 2019.
Chapter 3, the Telmisartan competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Telmisartan breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Telmisartan market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Telmisartan sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Telmisartan Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Telmisartan Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Injection
1.2.3 Freeze-Dried Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global Telmisartan Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Others
1.4 Overview of Global Telmisartan Market
1.4.1 Global Telmisartan Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bayer SWOT Analysis
2.2.4 Bayer Product and Services
2.2.5 Bayer Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Teva SWOT Analysis
2.4.4 Teva Product and Services
2.4.5 Teva Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hema Pharmaceuticals Pvt
2.5.1 Hema Pharmaceuticals Pvt Details
2.5.2 Hema Pharmaceuticals Pvt Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Hema Pharmaceuticals Pvt SWOT Analysis
2.5.4 Hema Pharmaceuticals Pvt Product and Services
2.5.5 Hema Pharmaceuticals Pvt Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boehringer Ingelheim SWOT Analysis
2.6.4 Boehringer Ingelheim Product and Services
2.6.5 Boehringer Ingelheim Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Astellas Pharma Inc
2.7.1 Astellas Pharma Inc Details
2.7.2 Astellas Pharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Astellas Pharma Inc SWOT Analysis
2.7.4 Astellas Pharma Inc Product and Services
2.7.5 Astellas Pharma Inc Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Reddy’s Laboratories (UK)
2.8.1 Reddy’s Laboratories (UK) Details
2.8.2 Reddy’s Laboratories (UK) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Reddy’s Laboratories (UK) SWOT Analysis
2.8.4 Reddy’s Laboratories (UK) Product and Services
2.8.5 Reddy’s Laboratories (UK) Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Mylan SWOT Analysis
2.9.4 Mylan Product and Services
2.9.5 Mylan Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GSK SWOT Analysis
2.10.4 GSK Product and Services
2.10.5 GSK Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Nippon Boehringer Ingelheim
2.11.1 Nippon Boehringer Ingelheim Details
2.11.2 Nippon Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Nippon Boehringer Ingelheim SWOT Analysis
2.11.4 Nippon Boehringer Ingelheim Product and Services
2.11.5 Nippon Boehringer Ingelheim Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Beijing Wansheng Pharmaceutical
2.12.1 Beijing Wansheng Pharmaceutical Details
2.12.2 Beijing Wansheng Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Beijing Wansheng Pharmaceutical SWOT Analysis
2.12.4 Beijing Wansheng Pharmaceutical Product and Services
2.12.5 Beijing Wansheng Pharmaceutical Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Abbott
2.13.1 Abbott Details
2.13.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Abbott SWOT Analysis
2.13.4 Abbott Product and Services
2.13.5 Abbott Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Takeda
2.14.1 Takeda Details
2.14.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Takeda SWOT Analysis
2.14.4 Takeda Product and Services
2.14.5 Takeda Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Telmisartan Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Telmisartan Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Telmisartan Manufacturer Market Share in 2019
3.3.2 Top 6 Telmisartan Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Telmisartan Sales, Revenue and Market Share by Regions
4.1.1 Global Telmisartan Sales and Market Share by Regions (2015-2020)
4.1.2 Global Telmisartan Revenue and Market Share by Regions (2015-2020)
4.2 North America Telmisartan Sales and Growth Rate (2015-2020)
4.3 Europe Telmisartan Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Telmisartan Sales and Growth Rate (2015-2020)
4.5 South America Telmisartan Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Telmisartan Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Telmisartan Sales, Revenue and Market Share by Country
5.1.1 North America Telmisartan Sales and Market Share by Country (2015-2020)
5.1.2 North America Telmisartan Revenue and Market Share by Country (2015-2020)
5.2 United States Telmisartan Sales and Growth Rate (2015-2020)
5.3 Canada Telmisartan Sales and Growth Rate (2015-2020)
5.4 Mexico Telmisartan Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Telmisartan Sales, Revenue and Market Share by Country
6.1.1 Europe Telmisartan Sales and Market Share by Country (2015-2020)
6.1.2 Europe Telmisartan Revenue and Market Share by Country (2015-2020)
6.2 Germany Telmisartan Sales and Growth Rate (2015-2020)
6.3 UK Telmisartan Sales and Growth Rate (2015-2020)
6.4 France Telmisartan Sales and Growth Rate (2015-2020)
6.5 Russia Telmisartan Sales and Growth Rate (2015-2020)
6.6 Italy Telmisartan Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Telmisartan Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Telmisartan Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Telmisartan Revenue and Market Share by Regions (2015-2020)
7.2 China Telmisartan Sales and Growth Rate (2015-2020)
7.3 Japan Telmisartan Sales and Growth Rate (2015-2020)
7.4 Korea Telmisartan Sales and Growth Rate (2015-2020)
7.5 India Telmisartan Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Telmisartan Sales and Growth Rate (2015-2020)
7.7 Australia Telmisartan Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Telmisartan Sales, Revenue and Market Share by Country
8.1.1 South America Telmisartan Sales and Market Share by Country (2015-2020)
8.1.2 South America Telmisartan Revenue and Market Share by Country (2015-2020)
8.2 Brazil Telmisartan Sales and Growth Rate (2015-2020)
8.3 Argentina Telmisartan Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Telmisartan Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Telmisartan Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Telmisartan Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Telmisartan Sales and Growth Rate (2015-2020)
9.3 Turkey Telmisartan Sales and Growth Rate (2015-2020)
9.4 Egypt Telmisartan Sales and Growth Rate (2015-2020)
9.5 South Africa Telmisartan Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Telmisartan Sales and Market Share by Type (2015-2020)
10.2 Global Telmisartan Revenue and Market Share by Type (2015-2020)
10.3 Global Telmisartan Price by Type (2015-2020)
11 Global Telmisartan Market Segment by Application
11.1 Global Telmisartan Sales Market Share by Application (2015-2020)
11.2 Global Telmisartan Revenue Market Share by Application (2015-2020)
11.3 Global Telmisartan Price by Application (2015-2020)
12 Market Forecast
12.1 Global Telmisartan Sales, Revenue and Growth Rate (2021-2025)
12.2 Telmisartan Market Forecast by Regions (2021-2025)
12.2.1 North America Telmisartan Market Forecast (2021-2025)
12.2.2 Europe Telmisartan Market Forecast (2021-2025)
12.2.3 Asia-Pacific Telmisartan Market Forecast (2021-2025)
12.2.4 South America Telmisartan Market Forecast (2021-2025)
12.2.5 Middle East & Africa Telmisartan Market Forecast (2021-2025)
12.3 Telmisartan Market Forecast by Type (2021-2025)
12.3.1 Global Telmisartan Sales Forecast by Type (2021-2025)
12.3.2 Global Telmisartan Market Share Forecast by Type (2021-2025)
12.4 Telmisartan Market Forecast by Application (2021-2025)
12.4.1 Global Telmisartan Sales Forecast by Application (2021-2025)
12.4.2 Global Telmisartan Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Telmisartan Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Telmisartan by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Telmisartan Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Telmisartan Major Business
Table 9. Pfizer Telmisartan Total Revenue (USD Million) (2018-2019)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Telmisartan Product and Services
Table 12. Pfizer Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Telmisartan Major Business
Table 15. Bayer Telmisartan Total Revenue (USD Million) (2018-2019)
Table 16. Bayer SWOT Analysis
Table 17. Bayer Telmisartan Product and Services
Table 18. Bayer Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Telmisartan Major Business
Table 21. Novartis Telmisartan Total Revenue (USD Million) (2018-2019)
Table 22. Novartis SWOT Analysis
Table 23. Novartis Telmisartan Product and Services
Table 24. Novartis Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Teva Basic Information, Manufacturing Base and Competitors
Table 26. Teva Telmisartan Major Business
Table 27. Teva Telmisartan Total Revenue (USD Million) (2018-2019)
Table 28. Teva SWOT Analysis
Table 29. Teva Telmisartan Product and Services
Table 30. Teva Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Hema Pharmaceuticals Pvt Basic Information, Manufacturing Base and Competitors
Table 32. Hema Pharmaceuticals Pvt Telmisartan Major Business
Table 33. Hema Pharmaceuticals Pvt Telmisartan Total Revenue (USD Million) (2018-2019)
Table 34. Hema Pharmaceuticals Pvt SWOT Analysis
Table 35. Hema Pharmaceuticals Pvt Telmisartan Product and Services
Table 36. Hema Pharmaceuticals Pvt Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 38. Boehringer Ingelheim Telmisartan Major Business
Table 39. Boehringer Ingelheim Telmisartan Total Revenue (USD Million) (2018-2019)
Table 40. Boehringer Ingelheim SWOT Analysis
Table 41. Boehringer Ingelheim Telmisartan Product and Services
Table 42. Boehringer Ingelheim Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Astellas Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 44. Astellas Pharma Inc Telmisartan Major Business
Table 45. Astellas Pharma Inc Telmisartan Total Revenue (USD Million) (2018-2019)
Table 46. Astellas Pharma Inc SWOT Analysis
Table 47. Astellas Pharma Inc Telmisartan Product and Services
Table 48. Astellas Pharma Inc Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Reddy's Laboratories (UK) Basic Information, Manufacturing Base and Competitors
Table 50. Reddy's Laboratories (UK) Telmisartan Major Business
Table 51. Reddy's Laboratories (UK) Telmisartan Total Revenue (USD Million) (2018-2019)
Table 52. Reddy's Laboratories (UK) SWOT Analysis
Table 53. Reddy's Laboratories (UK) Telmisartan Product and Services
Table 54. Reddy's Laboratories (UK) Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Mylan Basic Information, Manufacturing Base and Competitors
Table 56. Mylan Telmisartan Major Business
Table 57. Mylan Telmisartan Total Revenue (USD Million) (2018-2019)
Table 58. Mylan SWOT Analysis
Table 59. Mylan Telmisartan Product and Services
Table 60. Mylan Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. GSK Basic Information, Manufacturing Base and Competitors
Table 62. GSK Telmisartan Major Business
Table 63. GSK Telmisartan Total Revenue (USD Million) (2018-2019)
Table 64. GSK SWOT Analysis
Table 65. GSK Telmisartan Product and Services
Table 66. GSK Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Nippon Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 68. Nippon Boehringer Ingelheim Telmisartan Major Business
Table 69. Nippon Boehringer Ingelheim Telmisartan Total Revenue (USD Million) (2018-2019)
Table 70. Nippon Boehringer Ingelheim SWOT Analysis
Table 71. Nippon Boehringer Ingelheim Telmisartan Product and Services
Table 72. Nippon Boehringer Ingelheim Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Beijing Wansheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Beijing Wansheng Pharmaceutical Telmisartan Major Business
Table 75. Beijing Wansheng Pharmaceutical Telmisartan Total Revenue (USD Million) (2018-2019)
Table 76. Beijing Wansheng Pharmaceutical SWOT Analysis
Table 77. Beijing Wansheng Pharmaceutical Telmisartan Product and Services
Table 78. Beijing Wansheng Pharmaceutical Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Abbott Basic Information, Manufacturing Base and Competitors
Table 80. Abbott Telmisartan Major Business
Table 81. Abbott Telmisartan Total Revenue (USD Million) (2018-2019)
Table 82. Abbott SWOT Analysis
Table 83. Abbott Telmisartan Product and Services
Table 84. Abbott Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Takeda Basic Information, Manufacturing Base and Competitors
Table 86. Takeda Telmisartan Major Business
Table 87. Takeda Telmisartan Total Revenue (USD Million) (2018-2019)
Table 88. Takeda SWOT Analysis
Table 89. Takeda Telmisartan Product and Services
Table 90. Takeda Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Global Telmisartan Sales by Manufacturer (2018-2019) (MT)
Table 92. Global Telmisartan Revenue by Manufacturer (2018-2019) (USD Million)
Table 93. Global Telmisartan Sales by Regions (2015-2020) (MT)
Table 94. Global Telmisartan Sales Market Share by Regions (2015-2020)
Table 95. Global Telmisartan Revenue by Regions (2015-2020) (USD Million)
Table 96. North America Telmisartan Sales by Countries (2015-2020) (MT)
Table 97. North America Telmisartan Sales Market Share by Countries (2015-2020)
Table 98. North America Telmisartan Revenue by Countries (2015-2020) (USD Million)
Table 99. North America Telmisartan Revenue Market Share by Countries (2015-2020)
Table 100. Europe Telmisartan Sales by Countries (2015-2020) (MT)
Table 101. Europe Telmisartan Sales Market Share by Countries (2015-2020)
Table 102. Europe Telmisartan Revenue by Countries (2015-2020) (USD Million)
Table 103. Asia-Pacific Telmisartan Sales by Regions (2015-2020) (MT)
Table 104. Asia-Pacific Telmisartan Sales Market Share by Regions (2015-2020)
Table 105. Asia-Pacific Telmisartan Revenue by Regions (2015-2020) (USD Million)
Table 106. South America Telmisartan Sales by Countries (2015-2020) (MT)
Table 107. South America Telmisartan Sales Market Share by Countries (2015-2020)
Table 108. South America Telmisartan Revenue by Countries (2015-2020) (USD Million)
Table 109. South America Telmisartan Revenue Market Share by Countries (2015-2020)
Table 110. Middle East & Africa Telmisartan Sales by Countries (2015-2020) (MT)
Table 111. Middle East & Africa Telmisartan Sales Market Share by Countries (2015-2020)
Table 112. Middle East & Africa Telmisartan Revenue by Countries (2015-2020) (USD Million)
Table 113. Middle East & Africa Telmisartan Revenue Market Share by Countries (2015-2020)
Table 114. Global Telmisartan Sales by Type (2015-2020) (MT)
Table 115. Global Telmisartan Sales Share by Type (2015-2020)
Table 116. Global Telmisartan Revenue by Type (2015-2020) (USD Million)
Table 117. Global Telmisartan Revenue Share by Type (2015-2020)
Table 118. Global Telmisartan Sales by Application (2015-2020) (MT)
Table 119. Global Telmisartan Sales Share by Application (2015-2020)
Table 120. Global Telmisartan Sales Forecast by Regions (2021-2025) (MT)
Table 121. Global Telmisartan Market Share Forecast by Regions (2021-2025)
Table 122. Global Telmisartan Sales Forecast by Type (2021-2025) (MT)
Table 123. Global Telmisartan Market Share Forecast by Type (2021-2025)
Table 124. Global Telmisartan Sales Forecast by Application (2021-2025)
Table 125. Global Telmisartan Market Share Forecast by Application (2021-2025)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Telmisartan Picture
Figure 2. Global Sales Market Share of Telmisartan by Type in 2019
Figure 3. Injection Picture
Figure 4. Freeze-Dried Powder Picture
Figure 5. Telmisartan Sales Market Share by Application in 2018
Figure 6. Hospital Use Picture
Figure 7. Clinic Use Picture
Figure 8. Others Picture
Figure 9. Global Telmisartan Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Telmisartan Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Telmisartan Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Telmisartan Sales Market Share by Manufacturer in 2019
Figure 30. Global Telmisartan Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Telmisartan Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Telmisartan Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 35. Global Telmisartan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Telmisartan Revenue Market Share by Regions (2015-2020)
Figure 37. Global Telmisartan Revenue Market Share by Regions in 2018
Figure 38. North America Telmisartan Sales and Growth Rate (2015-2020)
Figure 39. Europe Telmisartan Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Telmisartan Sales and Growth Rate (2015-2020)
Figure 41. South America Telmisartan Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Telmisartan Sales and Growth Rate (2015-2020)
Figure 43. North America Telmisartan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Telmisartan Sales Market Share by Countries (2015-2020)
Figure 45. North America Telmisartan Sales Market Share by Countries in 2018
Figure 46. North America Telmisartan Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Telmisartan Revenue Market Share by Countries in 2018
Figure 48. United States Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 49. Canada Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 50. Mexico Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 51. Europe Telmisartan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Telmisartan Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Telmisartan Revenue Market Share by Countries in 2019
Figure 54. Germany Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 55. UK Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 56. France Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 57. Russia Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 58. Italy Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 59. Asia-Pacific Telmisartan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Telmisartan Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Telmisartan Revenue Market Share by Regions 2019
Figure 62. China Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 63. Japan Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 64. Korea Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 65. India Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 66. Southeast Asia Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 67. South America Telmisartan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Telmisartan Sales Market Share by Countries in 2019
Figure 69. South America Telmisartan Revenue Market Share by Countries in 2019
Figure 70. Brazil Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 71. Argentina Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 72. Middle East and Africa Telmisartan Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Telmisartan Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Telmisartan Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Telmisartan Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 77. Egypt Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 78. Turkey Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 79. South Africa Telmisartan Sales and Growth Rate (2015-2020) (MT)
Figure 80. Global Telmisartan Sales and Growth Rate (2021-2025) (MT)
Figure 81. Global Telmisartan Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Telmisartan Market Forecast (2021-2025) (MT)
Figure 83. Europe Sales Telmisartan Market Forecast (2021-2025) (MT)
Figure 84. Asia-Pacific Sales Telmisartan Market Forecast (2021-2025) (MT)
Figure 85. South America Sales Telmisartan Market Forecast (2021-2025) (MT)
Figure 86. Middle East & Africa Sales Telmisartan Market Forecast (2021-2025) (MT)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
凍結乾燥食品の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Freeze-Dried Food market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.4% in the forecast period of 2020 to 2025 and will expected to reach USD 58720 million by 2025, from USD 49510 million in 2019. The Freeze-Dried Food ma…- 凍結乾燥ペットフードの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Freeze-Dried Pet Food market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Freeze-Dried Pet Food m…
- フリーズドライ野菜の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Freeze Dried Vegetables market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Freeze Dried Vegetabl…
- 注射オキシトシンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Injection Oxytocin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Injection Oxytocin market …
- 注射用マムシ由来凝血促進剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Haemocoagulase Agkistrodon for Injection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Haem…